proprietary bsa-free synthetic blocking buffer (BioFX Laboratories Inc)
90
Structured Review
BioFX Laboratories Inc
proprietary bsa-free synthetic blocking buffer
Proprietary Bsa Free Synthetic Blocking Buffer, supplied by BioFX Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proprietary+blocking+buffer/proprietary+bsa+free+synthetic+blocking+buffer/pm22851004-66-41-47
Average 90 stars, based on 1 article reviews
Proprietary Bsa Free Synthetic Blocking Buffer, supplied by BioFX Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proprietary+blocking+buffer/proprietary+bsa+free+synthetic+blocking+buffer/pm22851004-66-41-47
Average 90 stars, based on 1 article reviews
proprietary bsa-free synthetic blocking buffer - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Saline:Article Title: Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide. Article Snippet: Galectin-3 (gal-3) is involved in the metastatic cascade and interacts with the cancer-associated carbohydrate, Thomsen-Freidenreich (TF) antigen during early stages of metastatic adhesion and tumor formation.. Our laboratory previously utilized bacteriophage display to select a peptide, G3-C12, with high specificity and affinity for gal-3 that was able to inhibit cancer cell adhesion.. We hypothesized that G3-C12 would inhibit TF/gal-3 and gal3/gal-3 interactions in vitro and in vivo and would moderate early steps of the metastatic cascade leading to reduced carcinogensis in vivo. Incubation:Article Title: Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide. Article Snippet: Galectin-3 (gal-3) is involved in the metastatic cascade and interacts with the cancer-associated carbohydrate, Thomsen-Freidenreich (TF) antigen during early stages of metastatic adhesion and tumor formation.. Our laboratory previously utilized bacteriophage display to select a peptide, G3-C12, with high specificity and affinity for gal-3 that was able to inhibit cancer cell adhesion.. We hypothesized that G3-C12 would inhibit TF/gal-3 and gal3/gal-3 interactions in vitro and in vivo and would moderate early steps of the metastatic cascade leading to reduced carcinogensis in vivo. Blocking Assay:Article Title: Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide. Article Snippet: Galectin-3 (gal-3) is involved in the metastatic cascade and interacts with the cancer-associated carbohydrate, Thomsen-Freidenreich (TF) antigen during early stages of metastatic adhesion and tumor formation.. Our laboratory previously utilized bacteriophage display to select a peptide, G3-C12, with high specificity and affinity for gal-3 that was able to inhibit cancer cell adhesion.. We hypothesized that G3-C12 would inhibit TF/gal-3 and gal3/gal-3 interactions in vitro and in vivo and would moderate early steps of the metastatic cascade leading to reduced carcinogensis in vivo. |
